# Agios Pharmaceuticals, Inc.: filings

AGIO · Nasdaq · CIK 1439222 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/agio.md) · [Financials](/companies/agio/financials.md) · [Filings](/companies/agio/filings.md) · [Insiders](/companies/agio/insiders.md)

## Reports and events: 270 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 702, 8-K 191, SC 13G/A 72, 144 61, 3 42, 10-Q 40, DEFA14A 23, S-8 18, SC 13G 17, 10-K 13, DEF 14A 13, CT ORDER 12, 4/A 11, 424B5 10, SCHEDULE 13G/A 9, UPLOAD 8, CORRESP 6, SCHEDULE 13G 6, S-3ASR 5, SC 13D/A 5, ARS 4, S-1/A 4, 424B4 2, D 2, EFFECT 2, S-1 2, 10-Q/A 1, 3/A 1, 5 1, 8-A12B 1, CERTNAS 1, DEFM14A 1, DRS 1, FWP 1, POSASR 1, PREM14A 1, S-1MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-30 | 09:56 ET | [10-Q](/filings/0001439222-26-000118.md) | Quarterly report, period 2026-06-30 | 0001439222-26-000118 |
| 2026-07-30 | 06:32 ET | [8-K](/filings/0001439222-26-000115.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-26-000115 |
| 2026-06-18 | 16:13 ET | [8-K](/filings/0001193125-26-275879.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-275879 |
| 2026-04-29 | 09:22 ET | [10-Q](/filings/0001439222-26-000073.md) | Quarterly report, period 2026-03-31 | 0001439222-26-000073 |
| 2026-04-29 | 06:32 ET | [8-K](/filings/0001439222-26-000071.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-26-000071 |
| 2026-04-24 | 16:01 ET | [DEF 14A](/filings/0001193125-26-177086.md) | Proxy statement, period 2026-06-18 | 0001193125-26-177086 |
| 2026-02-12 | 09:33 ET | [10-K](/filings/0001439222-26-000025.md) | Annual report, period 2025-12-31 | 0001439222-26-000025 |
| 2026-02-12 | 06:32 ET | [8-K](/filings/0001439222-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-26-000023 |
| 2026-01-12 | 07:11 ET | [8-K](/filings/0001439222-26-000018.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001439222-26-000018 |
| 2025-10-30 | 09:57 ET | [10-Q](/filings/0001439222-25-000116.md) | Quarterly report, period 2025-09-30 | 0001439222-25-000116 |
| 2025-10-30 | 06:32 ET | [8-K](/filings/0001439222-25-000114.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-25-000114 |
| 2025-08-04 | 13:53 ET | [8-K](/filings/0001439222-25-000090.md) | 7.01 Regulation FD disclosure | 0001439222-25-000090 |
| 2025-07-31 | 10:29 ET | [10-Q](/filings/0001439222-25-000089.md) | Quarterly report, period 2025-06-30 | 0001439222-25-000089 |
| 2025-07-31 | 06:38 ET | [8-K](/filings/0001439222-25-000087.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-25-000087 |
| 2025-07-08 | 07:01 ET | [8-K](/filings/0001439222-25-000076.md) | 5.02 Departure or appointment of officers or directors | 0001439222-25-000076 |
| 2025-06-18 | 16:31 ET | [8-K](/filings/0001193125-25-142745.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-142745 |
| 2025-05-01 | 10:26 ET | [10-Q](/filings/0001439222-25-000036.md) | Quarterly report, period 2025-03-31 | 0001439222-25-000036 |
| 2025-05-01 | 06:32 ET | [8-K](/filings/0001439222-25-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-25-000034 |
| 2025-04-25 | 16:03 ET | [DEF 14A](/filings/0001193125-25-096719.md) | Proxy statement, period 2025-06-18 | 0001193125-25-096719 |
| 2025-02-13 | 09:26 ET | [10-K](/filings/0001439222-25-000009.md) | Annual report, period 2024-12-31 | 0001439222-25-000009 |
| 2025-02-13 | 06:32 ET | [8-K](/filings/0001439222-25-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-25-000007 |
| 2025-02-13 | 06:01 ET | [8-K](/filings/0001193125-25-025524.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-025524 |
| 2025-01-13 | 07:01 ET | [8-K](/filings/0001193125-25-004943.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004943 |
| 2025-01-06 | 06:36 ET | [8-K](/filings/0001193125-25-001809.md) | 7.01 Regulation FD disclosure | 0001193125-25-001809 |
| 2024-10-31 | 09:20 ET | [10-Q](/filings/0001439222-24-000138.md) | Quarterly report, period 2024-09-30 | 0001439222-24-000138 |
| 2024-10-31 | 06:56 ET | [8-K](/filings/0001439222-24-000136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-24-000136 |
| 2024-08-01 | 09:49 ET | [10-Q](/filings/0001439222-24-000121.md) | Quarterly report, period 2024-06-30 | 0001439222-24-000121 |
| 2024-08-01 | 07:03 ET | [8-K](/filings/0001439222-24-000117.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-24-000117 |
| 2024-06-20 | 17:06 ET | [8-K](/filings/0001193125-24-164555.md) | 5.07 Shareholder vote results | 0001193125-24-164555 |
| 2024-05-28 | 07:09 ET | [8-K](/filings/0001193125-24-147583.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-147583 |
| 2024-05-02 | 09:20 ET | [10-Q](/filings/0001439222-24-000069.md) | Quarterly report, period 2024-03-31 | 0001439222-24-000069 |
| 2024-05-02 | 07:01 ET | [8-K](/filings/0001439222-24-000067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-24-000067 |
| 2024-04-26 | 16:02 ET | [DEF 14A](/filings/0001193125-24-117951.md) | Proxy statement, period 2024-06-20 | 0001193125-24-117951 |
| 2024-02-15 | 10:33 ET | [10-K](/filings/0001439222-24-000035.md) | Annual report, period 2023-12-31 | 0001439222-24-000035 |
| 2024-02-15 | 07:03 ET | [8-K](/filings/0001439222-24-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-24-000032 |
| 2024-01-08 | 07:58 ET | [8-K](/filings/0001193125-24-003920.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-003920 |
| 2023-11-02 | 09:20 ET | [10-Q](/filings/0001439222-23-000140.md) | Quarterly report, period 2023-09-30 | 0001439222-23-000140 |
| 2023-11-02 | 07:02 ET | [8-K](/filings/0001439222-23-000138.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-23-000138 |
| 2023-08-03 | 09:20 ET | [10-Q](/filings/0001439222-23-000119.md) | Quarterly report, period 2023-06-30 | 0001439222-23-000119 |
| 2023-08-03 | 06:38 ET | [8-K](/filings/0001439222-23-000117.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-23-000117 |
| 2023-06-14 | 16:05 ET | [8-K](/filings/0001193125-23-166855.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-166855 |
| 2023-05-25 | 16:02 ET | [8-K](/filings/0001193125-23-154190.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-154190 |
| 2023-05-04 | 09:55 ET | [10-Q](/filings/0001439222-23-000065.md) | Quarterly report, period 2023-03-31 | 0001439222-23-000065 |
| 2023-05-04 | 07:03 ET | [8-K](/filings/0001439222-23-000063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-23-000063 |
| 2023-04-26 | 16:03 ET | [DEF 14A](/filings/0001193125-23-118490.md) | Proxy statement | 0001193125-23-118490 |
| 2023-04-19 | 07:26 ET | [8-K](/filings/0001193125-23-105679.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-105679 |
| 2023-03-03 | 16:11 ET | [8-K](/filings/0001193125-23-060031.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-060031 |
| 2023-02-23 | 10:35 ET | [10-K](/filings/0001439222-23-000039.md) | Annual report, period 2022-12-31 | 0001439222-23-000039 |
| 2023-02-23 | 07:02 ET | [8-K](/filings/0001439222-23-000037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439222-23-000037 |
| 2023-01-09 | 07:18 ET | [8-K](/filings/0001193125-23-004143.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-004143 |

Page 1 of 6. [Older](/companies/agio/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:12 ET. No prices; not investment advice.